Legal Opinion
Lipitor (Atorvastatin Calcium) Mktg. v. Pfizer, Inc.
Court of Appeals for the Fourth Circuit
Decided June 12, 2018No. 17-1140; 17-1136; 17-1137; 17-1189PublishedCited by 121 opinions
1Opinion of the Court
DIAZ, Circuit Judge:
This appeal arises from a multidistrict litigation ("MDL") in which thousands of women claim that their use of the medication Lipitor caused them to develop diabetes. The women sued Pfizer, Lipitor's manufacturer, asserting various products liability claims. After protracted litigation, the district court granted summary judgment to Pfizer. Plaintiffs now ask us to consider a host of issues, including whether the district court erred in excluding certain expert testimony under Federal Rule of Evidence 702 and Daubert 1 ; whether it erred in requiring expert testimony at…
2Cases cited30 opinions
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- Erie Railroad v. TompkinsSupreme Court of the United States · 1938
- Kumho Tire Co. v. CarmichaelSupreme Court of the United States · 1999
- General Electric Co. v. JoinerSupreme Court of the United States · 1997
- Matrixx Initiatives, Inc. v. SiracusanoSupreme Court of the United States · 2011
25 more not listed; retrieve them via the Exa API.
3Cited by121 opinions
- Zoe Spencer v. Virginia State UniversityCourt of Appeals for the Fourth Circuit · 2019
- United States v. Michael SmithCourt of Appeals for the Fourth Circuit · 2019
- Cynthia Madej v. Jeff MaidenCourt of Appeals for the Sixth Circuit · 2020
- Edwin Hardeman v. Monsanto CompanyCourt of Appeals for the Ninth Circuit · 2021
- In re Accutane Litig.Supreme Court of New Jersey · 2018
116 more not listed; retrieve them via the Exa API.